Rescheduling of Bromazolam: emergency response to a growing public health issue
The DEA has emergency‑scheduled Bromazolam after its rise in counterfeit pills, warning of severe risks like respiratory depression and accidental overdose.
The DEA has emergency‑scheduled Bromazolam after its rise in counterfeit pills, warning of severe risks like respiratory depression and accidental overdose.
Many prevention efforts are driven by good intentions—but not all approaches create lasting impact. In this Pathways 2 Prevention episode, Matej (UTRIP), author of Prevention Gone Wrong, explains why “fast food prevention” fails and how prevention professionals can shift toward strategies that build real protective factors. Learn the 5-minute test to evaluate prevention initiatives and practical steps to strengthen programs that truly change behavior.
Drug Free America Foundation has submitted a formal contribution to [...]
A study posted in the Sage Journals reveals that despite [...]
The 13th Annual National Prevention Summit brought together nearly 200 professionals and 16 partner organizations for two powerful days of science-based prevention, recovery advocacy, and policy leadership. National experts addressed emerging drug trends, youth-targeted marketing, trauma-informed prevention, and digital risks—while strengthening collaboration across communities. Discover the highlights and how you can support prevention education nationwide.
Marijuana is often framed as “natural” and “safer than other [...]
The United States has seen a significant drop in opioid [...]
New NIH data reveals teen drug use remains historically low in 2025, with most adolescents abstaining from alcohol, marijuana, and nicotine.
Marijuana ads are targeting teens with youth-appealing imagery and misleading health claims. Learn how marketing normalizes use and why prevention awareness is critical.
Join us February 17–18, 2026, in St. Petersburg, Florida, for the 13th Annual National Prevention Summit hosted by Drug Free America Foundation. Featuring opening keynote Dr. Kevin Sabet, expert-led sessions, CEUs, and national leaders in prevention, treatment, recovery, and drug policy.